Equities Research Analysts’ Updated EPS Estimates for November 21st (AER, AIOT, AL, ARBK, ARGX, AZEK, BMEA, CAN, CBG, CMCX)

Equities Research Analysts’ updated eps estimates for Thursday, November 21st:

AerCap (NYSE:AER) had its buy rating reissued by analysts at The Goldman Sachs Group, Inc.. The Goldman Sachs Group, Inc. currently has a $119.00 price target on the stock.

Powerfleet (NASDAQ:AIOT) had its outperform rating reiterated by analysts at William Blair.

Air Lease (NYSE:AL) had its buy rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They currently have a $65.00 target price on the stock.

Argo Blockchain (NASDAQ:ARBK) had its neutral rating reissued by analysts at HC Wainwright.

argenx (NASDAQ:ARGX) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $675.00 price target on the stock, up from their previous price target of $646.00.

AZEK (NYSE:AZEK) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $55.00 price target on the stock.

Biomea Fusion (NASDAQ:BMEA) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $40.00 target price on the stock.

Canaan (NASDAQ:CAN) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $3.00 target price on the stock.

Close Brothers Group (LON:CBG) had its buy rating reaffirmed by analysts at Shore Capital.

CMC Markets (LON:CMCX) had its hold rating reiterated by analysts at Shore Capital.

Salesforce (NYSE:CRM) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. The firm currently has a $385.00 price target on the stock, up from their previous price target of $330.00.

DHI Group (NYSE:DHX) had its outperform rating reissued by analysts at Barrington Research. They currently have a $7.00 target price on the stock.

EnLink Midstream (NYSE:ENLC) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $15.00 target price on the stock.

Exact Sciences (NASDAQ:EXAS) had its outperform rating reissued by analysts at William Blair.

Ferro-Alloy Resources (LON:FAR) had its house stock rating reaffirmed by analysts at Shore Capital.

Farmers National Banc (NASDAQ:FMNB) had its neutral rating reaffirmed by analysts at Piper Sandler. The firm currently has a $17.00 price target on the stock.

Global-E Online (NASDAQ:GLBE) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $63.00 price target on the stock, up from their previous price target of $44.00.

Halma (LON:HLMA) had its hold rating reissued by analysts at Shore Capital.

Helmerich & Payne (NYSE:HP) had its hold rating reissued by analysts at Benchmark Co..

Jack in the Box (NASDAQ:JACK) had its hold rating reiterated by analysts at TD Cowen. The firm currently has a $50.00 price target on the stock.

Jack in the Box (NASDAQ:JACK) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $60.00 price target on the stock.

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $163.00 target price on the stock, down from their previous target price of $166.00.

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $207.00 target price on the stock.

JD Sports Fashion (LON:JD) had its buy rating reiterated by analysts at Shore Capital.

Kura Oncology (NASDAQ:KURA) had its overweight rating reissued by analysts at Cantor Fitzgerald.

Kura Oncology (NASDAQ:KURA) had its buy rating reaffirmed by analysts at TD Cowen.

Lisata Therapeutics (NASDAQ:LSTA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $15.00 price target on the stock.

Metagenomi (NASDAQ:MGX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $7.00 price target on the stock.

N-able (NYSE:NABL) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $15.00 target price on the stock.

NewAmsterdam Pharma (NASDAQ:NAMS) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $36.00 target price on the stock.

NovoCure (NASDAQ:NVCR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $30.00 target price on the stock.

NVIDIA (NASDAQ:NVDA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $175.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $175.00 target price on the stock.

NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at Bank of America Co.. They currently have a $190.00 price target on the stock.

Norcros (LON:NXR) had its buy rating reaffirmed by analysts at Shore Capital.

Norcros (LON:NXR) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 325 ($4.11) price target on the stock.

Origin Enterprises (LON:OGN) had its buy rating reaffirmed by analysts at Shore Capital.

Palo Alto Networks (NASDAQ:PANW) had its hold rating reaffirmed by analysts at Westpark Capital.

Palo Alto Networks (NASDAQ:PANW) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $450.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its market perform rating reaffirmed by analysts at Northland Securities. Northland Securities currently has a $370.00 target price on the stock, up from their previous target price of $350.00.

Palo Alto Networks (NASDAQ:PANW) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $445.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They currently have a $450.00 target price on the stock.

Pentair (NYSE:PNR) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $115.00 target price on the stock.

Pyxis Oncology (NASDAQ:PYXS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.

Rithm Capital (NYSE:RITM) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $13.00 target price on the stock.

Restore (LON:RST) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 380 ($4.81) target price on the stock.

Speedy Hire (LON:SDY) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 70 ($0.89) price target on the stock.

Sotera Health (NASDAQ:SHC) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $17.00 price target on the stock.

Snowflake (NYSE:SNOW) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $185.00 target price on the stock, up from their previous target price of $165.00.

Snowflake (NYSE:SNOW) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. The firm currently has a $180.00 price target on the stock.

Snowflake (NYSE:SNOW) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $210.00 price target on the stock.

STMicroelectronics (NYSE:STM) had its positive rating reissued by analysts at Susquehanna. Susquehanna currently has a $33.00 price target on the stock.

Trade Desk (NASDAQ:TTD) had its positive rating reaffirmed by analysts at Susquehanna. The firm currently has a $150.00 target price on the stock.

U.S. Physical Therapy (NYSE:USPH) had its outperform rating reissued by analysts at Barrington Research. They currently have a $108.00 target price on the stock.

Victorian Plumbing Group (LON:VIC) had its buy rating reiterated by analysts at Shore Capital.

Warehouse REIT (LON:WHR) had its hold rating reiterated by analysts at Shore Capital.

XPS Pensions Group (LON:XPS) had its hold rating reissued by analysts at Shore Capital.

XPS Pensions Group (LON:XPS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 401 ($5.07) price target on the stock.